Highland Capital Management (Texas)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-24,600
Closed -$1.58M 379
2018
Q4
$1.58M Hold
24,600
0.12% 128
2018
Q3
$2.2M Buy
+24,600
New +$2.17M 0.12% 132
2017
Q2
Sell
-23,100
Closed -$2.87M 376
2017
Q1
$2.87M Sell
23,100
-17,900
-44% -$2.14M 0.15% 127
2016
Q4
$4.75M Buy
41,000
+38,500
+1,540% +$4.29M 0.22% 107
2016
Q3
$261K Buy
+2,500
New +$271K 0.01% 281
2016
Q1
Sell
-194,631
Closed -$23.3M 311
2015
Q4
$23.3M Buy
194,631
+71,767
+58% +$8.3M 0.75% 35
2015
Q3
$13.3M Buy
122,864
+67,688
+123% +$8.4M 0.39% 75
2015
Q2
$6.39M Buy
+55,176
New +$6.31M 0.13% 148
2015
Q1
Sell
-18,700
Closed -$2.09M 287
2014
Q4
$2.09M Buy
+18,700
New +$1.97M 0.07% 135
2014
Q1
Sell
-19,108
Closed -$1.61M 268
2013
Q4
$1.61M Buy
19,108
+9,108
+91% +$721K 0.09% 89
2013
Q3
$771K Buy
+10,000
New +$701K 0.05% 120

Other funds holding CELG

Highland Capital Management (Texas)'s CELG Position: Q1 2019 in Review

Highland Capital Management (Texas) sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 24,600 shares — an estimated $1.58M sold.

Highland Capital Management (Texas) first reported a position in CELG in Q3 2013 and held it in 11 quarters. The position peaked at $23.3M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Highland Capital Management (Texas) reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 24,600 Celgene Corp shares in Q1 2019, an estimated $1.58M.
  • Highland Capital Management (Texas) first reported a position in Celgene Corp in Q3 2013 and held it in 11 quarters.
  • Highland Capital Management (Texas)'s Celgene Corp position peaked at $23.3M in Q4 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2019, filed 15 May 2019.